SC

Sangeetha Cheruvulliyil Rajan

Active Director Additional Director DIN 10723930
DIN 10723930 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangeetha Cheruvulliyil Rajan

Data last updated:

Sangeetha Cheruvulliyil Rajan is an Additional Director at Biokies Biotech Private Limited (since 2024).

DIN 10723930
Primary Designation Additional Director
First Appointment 01 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biokies Biotech Private Limited U56290KL2024PTC087739
Additional Director01 Aug 20242024Active

Board colleagues of Sangeetha Cheruvulliyil Rajan

Directorship timeline

Open interactive timeline →
Biokies Biotech Private Limited
Premium access

Shareholding and investment profile for Sangeetha Cheruvulliyil Rajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangeetha Cheruvulliyil Rajan

Sangeetha Cheruvulliyil Rajan currently holds 1 directorship: Biokies Biotech Private Limited (Additional Director, since 01 Aug 2024).

Sangeetha Cheruvulliyil Rajan was first appointed on 01 Aug 2024 as Additional Director at Biokies Biotech Private Limited.

The current boards of Sangeetha Cheruvulliyil Rajan's companies include Harikrishnan Radhakrishnan (Biokies Biotech Private Limited), Jibil (Biokies Biotech Private Limited), Sebastian Sachin (Biokies Biotech Private Limited), Vince Paul (Biokies Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available